Spark Investment Management’s Corcept Therapeutics CORT Stock Holding History

Spark Investment Management’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-116,400	Closed	-$1.38M	–	123
2020 Q1	$1.38M	Sell	116,400 -9,100	-7%	-$113K	0.74%	30
2019 Q4	$1.52M	Buy	+125,500	New	+$1.75M	0.18%	168
2018 Q1	–	Sell	-41,600	Closed	-$751K	–	612
2017 Q4	$751K	Buy	+41,600	New	+$753K	0.04%	398
2016 Q4	–	Sell	-104,400	Closed	-$678K	–	791
2016 Q3	$678K	Hold	104,400	–	–	0.05%	424
2016 Q2	$570K	Buy	+104,400	New	+$543K	0.05%	437
2015 Q2	–	Sell	-43,100	Closed	-$240K	–	674
2015 Q1	$240K	Sell	43,100 -13,800	-24%	-$50K	0.03%	516
2014 Q4	$170K	Buy	56,900 +35,100	+161%	+$107K	0.03%	517
2014 Q3	$58K	Sell	21,800 -400	-2%	-$1.06K	0.01%	624
2014 Q2	$62K	Buy	+22,200	New	+$65.5K	0.01%	586

Other funds holding CORT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Spark Investment Management's CORT Position: Q2 2020 in Review

Spark Investment Management sold out of Corcept Therapeutics (CORT) in Q2 2020, closing a stake of 116,400 shares — an estimated $1.38M sold.

Spark Investment Management first reported a position in CORT in Q2 2014 and held it in 9 quarters. The position peaked at $1.52M in Q4 2019. 224 funds tracked by Wall St. Rank hold CORT as of Q2 2020.

Spark Investment Management reported no remaining Corcept Therapeutics position as of Q2 2020 after selling out during the quarter.
Spark Investment Management sold 116,400 Corcept Therapeutics shares in Q2 2020, an estimated $1.38M.
Spark Investment Management first reported a position in Corcept Therapeutics in Q2 2014 and held it in 9 quarters.
Spark Investment Management's Corcept Therapeutics position peaked at $1.52M in Q4 2019.
224 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.